Cyclo-oxygenase-2 inhibitors and the kidney: A case for caution

Drug Safety

Volumn 25, Issue 3, 2002, Pages 165-172

  Noroian, Gary ^a   Clive, David ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FENOPROFEN; FLUOSIDE; IBUPROFEN; INDOMETACIN; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; ROFECOXIB; TOLMETIN; UNCLASSIFIED DRUG;

BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CREATININE CLEARANCE; DIGESTIVE SYSTEM INJURY; DIURESIS; DRUG SAFETY; ELECTROLYTE DISTURBANCE; ENZYME INHIBITION; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; HYPONATREMIA; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LYMPHOCYTIC INFILTRATION; NEPHROTOXICITY; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; SODIUM EXCRETION;

EID: 0036255339     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200225030-00003     Document Type: Review

References (41)

1. Utilization of nonsteroidal antiinflammatory drugs
2. Medical progress: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
3. NSAIDS: A Faustian bargain
4. Renal syndromes associated with nonsteroidal antiinflammatory drugs
5. Nonsteroidal antiinflammatory drugs and renal function
6. Renal complications associated with use of nonsteroidal antiinflammatory drugs
7. Incidence of hyperkalemia induced by indomethacin in a hospital population
8. Risk of kidney failure associated with the use of acetominophen, aspirin, and nonsteroidal antiinflammatory drugs
9. Adverse effects of nonsteroidal anti-inflammatory drugs on the kidney
10. Selective COX-2 inhibitors for arthritis: From bench to bedside
11. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
12. Cyclooxygenase-1 and cyclooxygenase-2 expression in rat kidney and adrenal gland after stimulation with systemic lipopolysaccharide: in situ hybridization and immunocytochemical studies
13. Interference of corticosteroids with prostaglandin E2 synthesis at the level of cyclooxygenase-2 mRNA expression in kidney cells
14. Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy
15. COX-2 and the kidneys
16. Cyclooxygenase-2 in the kidney
17. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice
18. Regulation of cyclooxygenase expression in the kidney by dietary salt intake
19. Cyclo-oxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
20. The macula densa of rat kidney and increases with salt restriction
21. Cyclo-oxygenase-2 mediates increased renal renin content induced by low sodium diet
22. Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal hemodynamics
23. Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition
24. Cyclo-oxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension
25. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake
26. Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure
27. Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis
28. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites
29. Natiuretic respone to increased pressure is preserved with COX-2 inhibitors
30. Effect of flosulide, a selective cyclooxygenase-2 inhibitor, on passive Heymann nephritis in the rat
31. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats
32. Selective increase of cyclooxygenase-2 expression in a model of renal ablation
33. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes
34. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet
35. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
36. Effects of celecoxib and naproxen on renal function in the elderly
37. An open study to assess the safety and tolerability of meloxicam 15 mg in subject with rhematic disease and mild renal impairment
38. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
39. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthrits and rheumatoid arthritis
40. Renal safety and tolerability of clelcoxib, a novel cyclooxygenase-2 inhibitor
41. Are selective COX-2 inhibitors nephrotoxic?